Detalles de la búsqueda
1.
The multispeciality approach to the management of localised kidney cancer.
Lancet
; 400(10351): 523-534, 2022 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35868329
2.
Erdafitinib in locally advanced/metastatic urothelial carcinoma with certain FGFR genetic alterations.
Future Oncol
; 18(19): 2455-2464, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35387485
3.
SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations-consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM).
Radiol Med
; 127(5): 534-542, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35303246
4.
Individualizing renal cell carcinoma treatment through biomarkers discovery in the era of immune checkpoint inhibitors: where do we stand?
Curr Opin Urol
; 31(3): 236-241, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33742982
5.
Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patients.
Clin Chem Lab Med
; 59(3): 581-589, 2021 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32383688
6.
Hepatocellular carcinoma, vascular endothelial growth factor receptors-targeting agents, and hypertension: A much more complicated relationship than expected.
Cancer
; 130(8): 1208-1209, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280211
7.
Opening an onconephrology clinic: recommendations and basic requirements.
Nephrol Dial Transplant
; 33(9): 1503-1510, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29982771
8.
Onco-nephrology: a decalogue.
Nephrol Dial Transplant
; 31(4): 515-9, 2016 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26341467
9.
Retrospective analysis on safety and efficacy of everolimus in treatment of metastatic renal cancer patients receiving dialysis.
Future Oncol
; 11(23): 3159-66, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26544922
10.
[The Outpatient Activity of the Onconephrology Clinic of Cremona in the First Semester of 2023].
G Ital Nefrol
; 41(1)2024 Feb 28.
Artículo
en Italiano
| MEDLINE | ID: mdl-38426682
11.
How to deal with renal toxicities from immune-based combination treatments in metastatic renal cell carcinoma. A nephrological consultation for Oncologists.
Cancer Treat Rev
; 125: 102692, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38492515
12.
Real-world usage of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) biomarkers in nephrology practices.
Clin Kidney J
; 17(1): sfad290, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38223338
13.
[Ten Years of Onconephrology].
G Ital Nefrol
; 40(Suppl 81)2023 Oct 03.
Artículo
en Italiano
| MEDLINE | ID: mdl-38007821
14.
[Management of Chemotherapy in Patients Subjected in Chronic Dialysis Treatment].
G Ital Nefrol
; 40(Suppl 81)2023 Oct 03.
Artículo
en Italiano
| MEDLINE | ID: mdl-38007825
15.
[The Treatment of Metastatic Renal Cell Carcinoma: An Update].
G Ital Nefrol
; 40(Suppl 81)2023 Oct 03.
Artículo
en Italiano
| MEDLINE | ID: mdl-38007832
16.
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience.
Oral Oncol
; 146: 106579, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37778228
17.
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey.
BJU Int
; 110(5): 692-8, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22364110
18.
Editorial Comment from Dr Porta et al. to Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the USA.
Int J Urol
; 24(4): 279-280, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28399614
19.
Treatment of acute kidney injury in cancer patients.
Clin Kidney J
; 15(5): 873-884, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35498895
20.
IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma.
Front Oncol
; 12: 990568, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36059687